Henry Schein (HSIC) Gets a Hold from Leerink Partners

Leerink Partners analyst Michael Cherny maintained a Hold rating on Henry Schein on October 14 and set a price target of $71.00. The company’s shares closed yesterday at $63.25.

Elevate Your Investing Strategy:

• Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

According to TipRanks, Cherny is a 4-star analyst with an average return of 5.1% and a 56.80% success rate. Cherny covers the Healthcare sector, focusing on stocks such as DENTSPLY SIRONA, McKesson, and Align Tech.

Henry Schein has an analyst consensus of Moderate Buy, with a price target consensus of $73.75.

HSIC market cap is currently $7.67B and has a P/E ratio of 20.34.

Based on the recent corporate insider activity of 59 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of HSIC in relation to earlier this year. Most recently, in August 2025, William Daniel, a Director at HSIC bought 10,000.00 shares for a total of $670,800.00.